Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Solano/Vallejo, San Mateo, San Francisco, Santa Rosa, Palo Alto/Santa Cruz, East Bay, Modesto, Greater Sacramento Valley
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Randomized Phase II/III Trial of First Line Platinum/Etoposide With or Without Atezolizumab (NSC#783608) in Patients With Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)